Some 2.6 million UK residents have diabetes and this number is rising. These people are at increased risk of heart disease, blindness and limb amputation. As part of Diabetes Week 2018, we have highlighted recent news and relevant articles about diabetes, including information about the condition and the treatment for it.
Pharmacists must be fully integrated into the care of people with type 2 diabetes mellitus in England across all care settings, the Royal Pharmaceutical Society has said.
A weekly dulaglutide injection in addition to existing medication reduces the risk of cardiovascular outcomes in individuals with type 2 diabetes mellitus, compared with placebo, a study published in The Lancet has found.
Pharmacy negotiators are in discussions with the government over reports that community pharmacists are being left out of pocket following a “surge” in prescriptions of a flash glucose monitoring device for people with type 1 diabetes mellitus.
Pharmacists can help patients with type 2 diabetes mellitus adopt a low-carbohydrate diet and reduce their medicines load.
HbA1c targets that ignore differences in the physiology of older patients put them at risk of severe hypoglycaemia, harm and death.
Almost one in three people with diabetes will experience a medication error during their hospital stay, an analysis by charity Diabetes UK has revealed.
UK needs far greater investment into diabetes research, Diabetes UK head of research says at RPS/UCL New Year lecture
The UK is a world leader in diabetes research, but urgently needs greater investment to translate that innovation into clinical practice.
The National Institute for Health and Care Excellence’s rudimentary approach to managing diabetes needs to catch up with the available evidence and put patients centre stage.
People diagnosed with type 2 diabetes will be placed on a new low-calorie diet as part of a pilot scheme to treat the condition, NHS England has announced.
All patients with diabetes who qualify for a flash glucose monitoring device will be able to receive it on prescription from April 2019, NHS England has announced.
Through analysing a randomly selected sample of patients with low blood glucose and diabetes over a course of a year, this prospective study found that a significant number of hypoglycaemia episodes were not treated to established protocol.
Sex and body mass index should be used to guide choice of second-line treatment for type 2 diabetes, a UK study has found.
Towards a smarter insulinSubscription
The diabetic footSubscription